Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet

Jan 12 2022

• By Reed Miller and Marion Webb

J.P. Morgan Daily Notebook 2022 Day 2 — • Source: Alamy

Related Content

Exec Chat: New iRhythm CEO Foresees Enormous Opportunity In AI For Arrhythmia Detection

Jan 06 2022

Zimmer Surgical Robot Class I Recall Due To Software Glitch

Oct 29 2021

Novocure Transforms Patient Support System During Pandemic

Sep 18 2020

Updated: iRhythm Continues To Grow Despite Reimbursement, Hospital-Staffing Challenges

Nov 05 2021

AAOS 2021: Digital Tools In Surgical Ecosystem, Software-Enabled Tech, Robots, Wearables, Sensors

Sep 10 2021

Biden Promises 500 Million COVID-19 Tests As Omicron Threatens To Overwhelm US Health Care System

Dec 21 2021

The Post-COVID Mantra For Medtechs: Prioritize, Optimize And Modernize

Dec 20 2021

Related Companies

Abbott

iRhythm Technologies, Inc.

Zimmer Biomet Holdings, Inc.

Apple Inc.

Microsoft Corporation

Canary Medical, Inc.

Additional Topics

Financing Business Strategies Digital Health Clinical Trials Companies Innovation Research & Development Commercial Deals Cardiovascular Cancer Infectious Diseases Renal Orthopedics Cardiology Diagnostics Patient Monitoring Robotics Robotic Surgery Medical Device

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window